The granzyme B inhibitor, protease inhibitor 9, is mainly expressed by dendritic cells and at immune-privileged sites
about
sameAs
The granzyme B inhibitor proteinase inhibitor 9 (PI9) is expressed by human mast cellsInduction of serine protease inhibitor 9 by Mycobacterium tuberculosis inhibits apoptosis and promotes survival of infected macrophagesEctopic expression of the serine protease inhibitor PI9 modulates death receptor-mediated apoptosisProteomics of human umbilical vein endothelial cells applied to etoposide-induced apoptosisStromal cell-based immunotherapy in transplantationInfection of semen-producing organs by SIV during the acute and chronic stages of the diseaseSerine proteinase inhibitor 9 can be recognized by cytotoxic T lymphocytes of epithelial cancer patientsDistribution of the human intracellular serpin protease inhibitor 8 in human tissuesInflammation converts human mesoangioblasts into targets of alloreactive immune responses: implications for allogeneic cell therapy of DMDSertoli cells--immunological sentinels of spermatogenesisBlockade of the granzyme B/perforin pathway through overexpression of the serine protease inhibitor PI-9/SPI-6 constitutes a mechanism for immune escape by tumors.Memory CD8+ T cells protect dendritic cells from CTL killing.Delivery and therapeutic potential of human granzyme B.Death by a thousand cuts: granzyme pathways of programmed cell deathIntracellular versus extracellular granzyme B in immunity and disease: challenging the dogma.Role of protease inhibitor 9 in survival and replication of Mycobacterium tuberculosis in mononuclear phagocytes from HIV-1-infected patientsPediatric Primitive Neuroectodermal Tumors of the Central Nervous System Differentially Express Granzyme InhibitorsInhibition of Granzyme B by PI-9 protects prostate cancer cells from apoptosis.Expression of the serpin serine protease inhibitor 6 protects dendritic cells from cytotoxic T lymphocyte-induced apoptosis: differential modulation by T helper type 1 and type 2 cells.Surface cathepsin B protects cytotoxic lymphocytes from self-destruction after degranulationThe human serpin proteinase inhibitor-9 self-associates at physiological temperatures.A Pulmonary Perspective on GASPIDs: Granule-Associated Serine Peptidases of Immune Defense.Oropharyngeal squamous cell carcinomas differentially express granzyme inhibitors.Expression of high levels of human proteinase inhibitor 9 blocks both perforin/granzyme and Fas/Fas ligand-mediated cytotoxicity.Granzyme C supports efficient CTL-mediated killing late in primary alloimmune responses.Intrahepatic lymphocyte expression of dipeptidyl peptidase I-processed granzyme B and perforin induces hepatocyte expression of serine proteinase inhibitor 6 (Serpinb9/SPI-6).The role of serpinb9/serine protease inhibitor 6 in preventing granzyme B-dependent hepatotoxicity.The role of serpins in vertebrate immunity.Serpins in T cell immunity.Intracellular and extracellular serpins modulate lung disease.Serine protease inhibitors and cytotoxic T lymphocytes.Modulators of inflammation use nuclear factor-kappa B and activator protein-1 sites to induce the caspase-1 and granzyme B inhibitor, proteinase inhibitor 9.Diverse endometrial mRNA signatures during the window of implantation in patients with repeated implantation failure.Mesenchymal stem cells express serine protease inhibitor to evade the host immune response.Ex vivo detection of primary leukemia cells resistant to granule cytotoxin-induced cell death: a rapid isolation method to study granzyme-B-mediated cell death.Reduced serpinB9-mediated caspase-1 inhibition can contribute to autoinflammatory disease.Design and characterization of a novel human Granzyme B inhibitor.High numbers of granzyme B/CD8-positive tumour-infiltrating lymphocytes in nasopharyngeal carcinoma biopsies predict rapid fatal outcome in patients treated with curative intent.Suppression of granzyme B activity and caspase-3 activation in leukaemia cells constitutively expressing the protease inhibitor 9.Granzymes in cytolytic lymphocytes--to kill a killer?
P2860
Q24297110-4077AAE1-2F4D-4D31-9593-1A5B7DB7224DQ24297607-1DEB87D6-7319-4495-8AB1-DB5525E1AD3EQ24304892-0C8B68D9-31D0-45AB-B8DA-087A05E46B42Q24318932-412A072C-6A06-441C-8C91-0BCA60C2F5D0Q26851908-6CD06BE6-F5AA-4A3B-B5F9-CFCD304F1F7CQ27301766-8D3D0314-FAD7-440E-9CA2-54E69567DEE6Q28202640-4AA27E84-F34D-4E29-ACD3-8A643A30CB4EQ28213636-06756A8B-53DE-4EB8-858E-BF3934D6E0CDQ28389778-29B024F7-CF8C-44FC-AE22-1974294D72A3Q33707016-A4FF71E4-58B1-4765-94A0-E628BAB76905Q33944674-2800BB8B-BCBB-4C79-8E42-5388CFCCCD9FQ34000039-51297084-B936-45F8-BEB1-16E1F8B01502Q34120062-5C46D6EA-6A7C-4440-95C5-63B1CEE91092Q34588821-14D479AE-61CB-40F1-872C-CA0D85B11EA1Q35004399-E36AB79F-9D47-4AC7-BC2D-BCC686435DBFQ35679772-FA415DA7-4CE7-42E2-A719-7A9AA02DCA27Q35952443-7998CAE2-1706-4043-BDBF-8C9A59E211DDQ36106303-AA474619-5BC3-40EE-B358-E8E3601532BCQ36376315-E72B449C-3579-4C5D-BCBA-79C2423DF1C3Q36376590-0D73E20F-132B-4DF4-9F04-C1ED95FEDE0DQ36519309-D9A50FEE-0EBD-4670-8E14-E250921FC763Q36688774-090AFB60-752F-4AF6-8A6B-8689FD8A2FD3Q36823719-E6D859F5-1566-4E9D-9AC4-66F38BAB6ACAQ36849529-3D44B104-1FF6-4BDB-9F60-3347C9310C8CQ37124795-45FE7093-7B15-49E0-91F0-AB1615D9E1E3Q37124811-F6DE7592-833D-4CBB-9486-E99E121F4C49Q37137513-9B86B2AB-89CB-4BD3-825B-1793872F52C3Q37170955-5B778FFE-A2AF-4FA7-8B9C-E88D77E8C626Q37222018-8770097C-300B-4DAF-BF49-02637AA7E902Q37341652-0B2B46C3-C2CA-4928-A22A-BEE509A42D23Q37763997-8836D19A-7680-42B8-AA57-21B4FE54EB51Q38363673-F2FB4F70-4015-4257-BDA0-4D3A89E9F102Q38433412-70A2E46B-A721-44A7-B61C-F82543F5279FQ39817392-01861E59-7F28-42CE-B890-8C699B4A555EQ39988225-4CBFC443-95D0-444D-9CFD-92948C5F6FEFQ41539053-99A4C88D-9F6E-49CD-B90E-5D5A2602F164Q41708310-682C6966-CA96-4E02-9EC6-56F164C45E79Q44218349-189CB6C3-232A-491D-B546-343C7A6A002BQ44357543-28671491-A989-41AF-BA6C-1527277AB504Q44828233-3BDBC67D-ED57-474C-B73A-5C77CE6BAE13
P2860
The granzyme B inhibitor, protease inhibitor 9, is mainly expressed by dendritic cells and at immune-privileged sites
description
2001 nî lūn-bûn
@nan
2001 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի մարտին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
The granzyme B inhibitor, prot ...... and at immune-privileged sites
@ast
The granzyme B inhibitor, prot ...... and at immune-privileged sites
@en
The granzyme B inhibitor, prot ...... and at immune-privileged sites
@nl
type
label
The granzyme B inhibitor, prot ...... and at immune-privileged sites
@ast
The granzyme B inhibitor, prot ...... and at immune-privileged sites
@en
The granzyme B inhibitor, prot ...... and at immune-privileged sites
@nl
prefLabel
The granzyme B inhibitor, prot ...... and at immune-privileged sites
@ast
The granzyme B inhibitor, prot ...... and at immune-privileged sites
@en
The granzyme B inhibitor, prot ...... and at immune-privileged sites
@nl
P2093
P1476
The granzyme B inhibitor, prot ...... and at immune-privileged sites
@en
P2093
B A Bladergroen
C J Meijer
G L Scheffer
J A Kummer
N Bovenschen
O van Berkum
P304
P356
10.4049/JIMMUNOL.166.5.3218
P407
P577
2001-03-01T00:00:00Z